Alzheimer's screening tests are commonly used by doctors to diagnose the patient's condition and stage as early as possible. Most of these tests are based on pen-paper interaction and do not embrace the advantages provided by new technologies. This paper proposes novel Alzheimer's screening tests based on virtual environments and game principles using new immersive technologies combined with advanced Human Computer Interaction (HCI) systems. These new tests are focused on the immersion of the patient in a virtual room, in order to mislead and deceive the patient's mind. In addition, we propose two novel variations of Turing Test proposed by Alan Turing as a method to detect dementia. As a result, four tests are introduced demonstrating the wide range of screening mechanisms that could be designed using virtual environments and game concepts. The proposed tests are focused on the evaluation of memory loss related to common objects, recent conversations and events; the diagnosis of problems in expressing and understanding language; the ability to recognise abnormalities; and to differentiate between virtual worlds and reality, or humans and machines.
Introduction
Dementia is a term used to encompass a number of symptoms such as the decline of memory, reasoning, language or perceptual interpretation. Specific combinations of these symptoms are used to define different types of dementia such as Alzheimer's or Parkinson's disease. Alzheimer is a disease that usually affects elder people, with the number of cases increasing over the last decades.
The number of people with early onset dementia (people under 65 years old) has also increased in the UK and worldwide [1] . Alzheimer's is the most common type; it accounts for 60 to 80 percent of cases, and one of the most noticeable symptoms is the difficulty in learning new information. In addition, when the disease advances, there are other symptoms such as disorientation, mood and behaviour changes; confusion about events, date and place; being suspicious about family, friends and caregivers; and difficulty in speaking, writing and walking [2] .
According to the World Health Organization, 1.37% of the estimated deaths around the world in 2030 will be caused by Alzheimer's disease and other dementias. People with medium dementia live on average 8 years [2] . Currently, when Alzheimers disease (AD) is diagnosed, the neuronal damage is spread enough to make it irreversible [3] . When neurons die, the other neurons do not divide and replace them, as other cells do, so the damage cannot be reversed [2] . Therefore, it is important to detect dementia at its very early stages in order to reduce the deterioration speed [4, 5] .
The cost of dementia is another issue to take into consideration. The worldwide cost of dementia is $818 billion, and it will become a trillion by 2018 [6] .
The cost of dementia in the UK estimated in 2013 was 26.3 billion pounds; 4.3 billions were spent on healthcare costs, of which around 85 millions were spent on diagnosis [1] . Therefore, it is essential to develop affordable diagnosis and
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support tools, limiting the increasing cost of dementia. One of the proposed initiatives is focused on the implementation of e-health (the use of Information Communication Technology (ICT)) solutions to reduce the cost and to make the health systems and solutions universally accessible [7] . Arief et al presented in [6] the strengths of e-health tools such as the improvement in accessing healthcare services by senior citizens, their cost-effectiveness and their efficiency in managing health resources.
Furthermore, Alzheimer's symptoms are studied to improve the results of previous approaches or create novel and more accurate methods relying on new affordable and publicly available technologies. Alzheimer's detection methods can be classified in two different categories: invasive and non-invasive. Invasive methods require obtaining data from the interior of the patient's body trough procedures such as lumbar puncture or blood extraction. These tests are not always safe and comfortable for the patient, while some of them are unbearably painful. On the other hand, non-invasive tests are harmless and more convenient during the diagnosis process.
Focusing on non-invasive methods, cognitive test are the most commonly used Alzheimer tests for diagnosis. These are question/task/problem based trying to measure patients cognition, while cognition is defined as the use of the information that has been previously collected by a person to make behavioural decisions [8] . Cognitive or aptitude tests have high accuracy when it comes to Alzheimers detection. Nevertheless, one of their weaknesses is the evaluation of brain's capacity to compensate brain damage (cognitive reserve) [3, 5] . Another well-know problem is the adaptability of the tests according to the patient's IQ, since most of the tasks that integrate an Alzheimers detection cognitive test usually are too simple to evaluate intelligent patients. Therefore, it is necessary to create tests, whose results are not correlated with the IQ of the patients. The use of computerized tests helps to create intelligence adaptable cognitive tests [9, 3] . Moreover, based on the available technology, it is possible to design new types and more effective tests using for example virtual environments (VEs).
Virtual environments provide additional advantages to cognitive tests, since it A C C E P T E D M A N U S C R I P T
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is possible to immerse the patient in a controlled situation [10, 11, 12, 13] .
Parsons et al. have demonstrated in [14, 15, 16] the ecological validity of VEs and their benefits for neurocognitive assessment, such as the precision of data retrieved by the computer or the better control of the environment. They also prove the advantages of using virtual reality over the traditional pen and paper methods.
When it comes to the Alzheimer's symptoms, the American Psychiatric Association has gathered in [17] [18] . In order a computer is considered intelligent should posses the next capabilities [19] : natural language processing, knowledge representation, automated reasoning and machine learning. Comparing these capabilities with the correspondent cognitive domains it is possible to consider the use of existent Turing Test for evaluating human cognition. In addition, according to Warwick et al [20] , the success of Turing test does not depend only in the quality of computer's AI; it also depends on the intelligence of the human that is judging the machine. Therefore, reversing this test, it is possible to obtain a cognitive test that checks the degree of intelligence or the existence of a cognitive impairment.
In this paper, we propose novel cognitive and executive function based, noninvasive screening tests for early Alzheimers diagnosis implemented as an ehealth tool. These new tests are conducted in a virtual room due to the flexibility to create different tasks and the capacity of the involved users, [10, 12, 13] . The developed test has been chosen following the next principles: it should evaluate A C C E P T E D M A N U S C R I P T
at least one of cognitive domain, it should take advantage of VEs flexibility and it should be easily upgraded. As a result, an innovative, cost efficient and flexible e-health Alzheimer's detection application is introduced.
The remainder of this paper is organized as follows: section 2 describes previous related work on Alzheimers diagnosis. Section 3 analyses the proposed methodology and in section 4 details on the evaluation process and the obtained results are presented. Section 5 gives some conclusion remarks.
Previous Work
Apart from the invasive/non-invasive classification, the Alzheimer's detection methods can also be classified as non-cognitive and cognitive tests. Cognitive tests encompass the methods that evaluate patients' cognition and these procedures are non-invasive and easy to implement. Non-cognitive tests are regarded all other methods, invasive or non-invasive, used to detect and diagnose dementia.
Regarding the non-cognitive approaches, in [2, 21] for Alzheimers disease detection, so they cannot be used in medical clinics [2] .
There are other non-invasive methods that require the use of external devices during a certain period of time to analyse patients behaviour [? 24] . For example, Aztiria et al in [24] placed a sensor on the patients foot in order to analyse their gait (step length and step height), since it reflects patients dementia level. However, the gait measurement method still has some drawbacks, such as the patient has to wear a device for long periods and the results obtained, despite being promising, are still not useful, since they have not been tested in [28] . Also it should be mentioned that the Mini Mental State Examination (MMSE) is one of the most well-known and used tests [29] . Other examples of cognitive tests not included in [27] are the memorization of interacting objects in the Visual Association Test (VAT) [30] or the detection of the prevalence of the right ear when sounds are memorized by Alzheimer's patients during the Dichotic Listening test [31] . The results provided by this test demonstrate high accuracy and specificity. Nevertheless, the results show a ceiling effect, since the test is not complex enough for high IQ patients [29] .
Other non-invasive methods are focused on analysing visual impairments since visuospatial functions and visual processes decline due to Alzheimer [32, 33] . These methods evaluate the mental state of a patient through the measurement of the reaction time in certain stimulus, the assessment of attention or
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the evaluation of patients visual memory [33, 34] . Pereira, et al. [33] analysed different methods that use eye-movement to determine visual impairments in Alzheimer patients. These methods compared eye movements of healthy people with Alzheimer patients in terms of fixation duration, refixations or saccade orientation. As a result, most of the studies revealed an increment of saccades, defects in fixations and slow pursuit movements. Nevertheless, as suggested by Pereira et al in [33, 34] , these studies fail to consider attentional impairments as a multi-domain concept and their results still need to be corroborated by future studies.
Recently, due to the new advances in computer technologies, Virtual Environments (VEs) started to become part of medical tests and rehabilitation therapies. The study conducted by García-Betances et al in [13] shows the advantages of virtual environments for Alzheimer's disease and point out the lack of immersion or interaction in most of the current virtual reality applications.
The work presented by Tarnanas, et al. in [11] demonstrates that the use of VEs is beneficial, when it comes to early dementia detection. It is possible to improve the results from previous cognitive tests, since it reduces the floor and the ceiling effects, creating tests that adapt to the patients' IQ; and it is possible to increase immersion in the task that is in progress. Their work uses large screens to display the environment and some depth sensors to recognize the gestures of the patients' body. This approach requires the patient to move to the location where the facilities for this test are available, due to the fact that the components are not portable and cost efficient making it inappropriate for e-health applications.
Recently approaches were introduced to validate the use of virtual reality for neurocognitive assessment. The work presented in [16] asses complex attention on healthy and military subjects and examine the ecological validity of virtual reality using head mounted VR devices in comparison with less immersive conditions. In [35] the authors evaluate learning and memory cognitive abilities on healthy controls while navigating through a virtual environment using a head mounted VR device. The test is based on traditional neurocognitive methods
proving the correlation between their and the traditional tests' results. Cushman et al. in [36] also present a comparative study between a navigation system on VEs and the real world while evaluating Alzheimer's participants navigation aptitudes and proving the ecological validity of VR environments. Parson et al work in [14] analyse the appropriate way to create neurocognitive interfaces in VEs. In this paper they consider the possible lost of the experimental control related with the VE fidelity. An increase of the VE fidelity means a loss in the control so a balance should be found in relation with the test type. Another interesting concept is the physchophysiological computing; this term implies the human monitoring by the computer being able to create user adaptive applications.
Relation with the proposed work
In our work a novel non-invasive Alzheimer's detection screening test based on VEs is proposed. The Virtual Environment created for this test is a room that the patients can recognize and feel comfortable, such as a doctor's office, a living room, etc. The use of new immersive technologies, such as virtual reality glasses, provides a huge improvement in immersing the subjects in a VE and its combination with depth cameras makes possible the improvement of interaction with the VE. The proposed and developed tool is the first Alzheimer's detection screening test that provides a full immersion in Virtual Environments implying that the patients are able to be more focused on the tasks, while additional information related to the environment-patient interaction is obtained. Also, it is possible to adapt some of the tasks to the patient's IQ level during the test, avoiding the ceiling effect. The adaptability to the participant's IQ is based on user's options election during the procedure and the test supervisor criteria, therefore it is not related with the physchophysiological computing concept presented in [14] .
These test are based on the examination of cognitive abilities. Therefore, the tests are question and task based, trying to provide a user friendly and comfortable environment for the patients. Furthermore, the proposed tests do not consider only memory tasks, but introduce novel approaches based on the concept of differentiating between reality and a virtual world; and on a new cognitive test that aims to identify normal and abnormal events or objects present in the virtual scene. Also, novel checks are proposed based on a reversed
Turing test, where the patients' cognition is evaluated according to their ability in distinguishing absurd from correct information or a machine from a human.
Proposed Methods
The proposed methods for Alzheimer's detection were developed to be conducted in Virtual Environments. Thus, VR glasses are used in order to maximize the patients' immersion in the VE and a depth camera is utilised to track the patients' movements and animate their avatars in order to increase the interactivity (see figure 1 ). These tools are affordable and they can be reused by other patients, resulting to a low cost Alzheimers detection application. The main scene was designed such as to recreate a doctor's office or any other real room that the patient can recognize (office, living room), see figure 2 . Then, the tests were designed taking advantage of the virtual environment versatility, such as the absence of physical limits.
Regarding the real environment, since Alzheimer's patients are mainly el- 
Virtual Objects Memorization test (VOM)
VOM is a test focused on memory and its main objective is the analysis of patients learning and memory cognitive domain [17] . It is split into three steps.
The first step of this memory test is the recognition of six different virtual objects. The objects are commonly used during everyday activities making them easily identified and recognized. The objective of this first task is to check if the patient has problems in recognizing quotidian objects (see figure 5 ). Once all the objects are recognized, a virtual monitor displays all of them in specific positions (the positions of these objects are the ones where they normally are located on a desk). Therefore, the patient is asked to memorize the objects but nothing is mentioned about their position.
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During the second step, the subject is asked about the objects' locations, in order to check the visual and the associative memory of the patient. In more details, the desk is shown in front of the patient and a number appears in the position where an object was located, while a list of the six possible objects is provided (see figure 6 ). The subjects are asked about the object that was located in the position indicated by a number and they have to select the name of the correct one. The fact that the objects were located in logical positions should help the user to select the right answers.
Finally, in the last task, interacting objects are placed in the virtual room and have to be located and memorized by the patient. Then, one of the objects is shown and the subject has to recall its interacting couple and their functionality.
Once the third stage is completed, there is an extra task associated with the first step, where the patient is asked to recall the objects that were shown. The aim of the last two tasks is to evaluate the patient's short-term memory incorporating interacting objects and their functionalities. So, the novel part here is focused
(a)
(c) mainly on the combination of interacting objects with their functionalities.
Also, it should be mentioned that in order to proceed through the test, the subject has to select amongst different options. This selection is performed moving the head to aim towards the desired option using the direction of view (scope), as we can see in Figures 5 and 6 . Therefore, the patients have to move slightly their head to fulfil the tasks.
This test if all tasks are completed successfully provides in total 21 points.
The points are associated with the recognition of the objects, the recall of their position and the recall of the objects themselves and their functionality.
Abnormal Objects Recognition test (AOR)
AOR is a test that evaluates if the patient is able to discern if something is abnormal or not within the virtual environment and it is divided into three [17] . Table 1 describes the abnormalities that can be find in the room.
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The subject in the second stage is requested to read the clock that is located on one of the walls in the room. Shortly afterwards the patient is asked if the illumination (i.e. ambient light) of the room is in accordance with the time, (see Figure 7) .
Finally, the objective of the third stage is to evaluate the coordination of the patient when the physics of a mirror reflection are changed. An avatar, whose movements are linked to the patients movements, is displayed in front of them.
Therefore, it will look like a mirror; however, the movements of the avatar are reversed. Once the patients detect how the avatar moves, they are asked to perform specific movements with the avatar (see table 2 ). This task allows the study of perceptual-motor and executive function impairment [17] .
This test can provide a maximum of 10 points. Seven points are associated with the correct detection of the abnormalities and three are associated with the correct movement of the avatar.
Virtual vs Real Sounds test (VRS)
The main objective of VRS test is the detection and recognition of objects/events through audio and to check if the patient is able to discern between real and virtual sounds. As a result this test analyses patients' mental and cognitive flexibility [17] .
Different sounds are played during the test, such as a clock ticking, a fly, Figure 9 : Selection Based -Bot Doctor Turing Test preview. The two avatars represent a doctor. The closest one is the one asking the questions in the screen, once it finishes the other avatar will move to the position of this avatar and ask it will ask its questions. The participant has to read the information above and choose one of the options below moving the scope over the desired choice using head movements.
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rain at the background, etc., (see Figure 8) . The patient has to recognise and name all the sounds that they listen during the test. In addition, the virtual environment will provide some visual clues to help them with the identification.
Once the subjects have identified all the sounds, they are asked about the origin of the sounds. During this stage, the source of some sounds is coming either from the virtual environment or the real world reproduced by the supervisor.
This second part requires the patient to recall all the sounds that were played and to identify which ones were reproduced by the supervisor. This test gives a maximum score of 6 points. One point is obtained for each object that is recognized and categorized properly as real or virtual.
Bot-Doctor Turing Test (BDTT)
The proposed Turing test is based on the ability of a patient to evaluate if a computer is able to impersonate a human. In order to perform the test, a human and a computer are located in a room, while the patient is in another location trying to communicate with the human and the computer in the first room without knowing who is responding, (see Figure 9 ). The patient in the second room asks questions aiming to distinguish who is the human and who is the
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computer [18] . We propose two different versions of the Alzheimer Turing test to evaluate patients' executive function, such as the ability to hold information and manipulate it and assess their process of making decisions [17] .
Selection Based -Bot-Doctor Turing Test
In this test two virtual doctors have been designed to provide answers about a specific topic to the patient based on a simple AI architecture. The conversation is formatted using a tree structure and is based on the same discussion and interaction system used in classic adventure video games. In more details, the discussion system provides a set of questions to the patients and based on their choice the AI-Bot-Doctors will provide an answer. The patient is informed that will have two discussions with two different Bot-Doctors and each AI system provides related but different answers. One of them will provide logical and correct answers, whereas the other will provide incorrect and sometimes absurd responses.
The whole discussion takes place in a virtual room, and two different human 
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Script Based Bot-Doctor Turing Test
The second Alzheimer Turing test that is suggested is script based using chatbots. Chatbots are defined as computer programs that can maintain a conversation with a person [37] . ELIZA, IBM's Watson and Apple's Siri are some of the most famous chatbots. ELIZA was the first chatbot and was created by Joseph Weizenbaum; IBM's Watson is a chatbot that won in Jeopardy TV show in 2011; and Apple's Siri is the iPhone's personal assistant application.
Also, many open source chatbots are available such as ALICE that can be used in this Bot-Doctor Turing test.
In order to interact with chatbots, people start a chat with the AI, they write the messages on the computer chat screen and the AI or human will engage in conversation. If voice recognition and synthesis are supported then this option can be selected. The proposed test uses a chatbot (e.g. ALICE) and a human to have a discussion with the patient. Therefore, all the entities that are involved in this test are the same as the used in a Turing Test, two humans and one computer. The patients are asked to chat for five minutes with each entity and, at the end, they are asked to decide which entity is a human. The intelligence of the chatbot is settled in accordance with patient's IQ in order to avoid the ceiling effect. It is expected that Alzheimer's patients fail distinguishing a simple AI based chatbot from a human. Regarding the scoring system, this test provides exactly the same points as the previous one.
Results
Participants
The 20 participants of this test are aged between 23 and 82 year old including both healthy people and Alzheimer's patients diagnosed with mild dementia less than year ago. Furthermore, Alzheimer's patients in advanced conditions were tested but, the process was not possible to be completed. Half the subjects were male and the other half female of whom eleven had college or higher educational
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background and nine did not reach high school. None of the Alzheimer's participants' education level reached high school. The participants' nationalities included French, Spanish, Vietnamese and Greek so the non English speakers were tested in their own language. It has to be mentioned that one of the patients was illiterate so the test was performed orally.
Data
The main data collected during the experiment are the individual scores for each test. As it was explained in section 3, each test has a maximum score and each task provides a different number of points. In more details, regarding the recognition and memory tasks, each recalled and recognized object scores 1 point.
In addition, patients have been also tested using other well-known state of the art Alzheimer screening tests, in order to perform a comparative study and allow the evaluation of the proposed novel non-invasive diagnosis screening tests.
All the tests were computerized so the patients have to use a computer through the whole process retaining also the same conditions among all tests. The stateof-the-art screening tests used in our comparative study are Dr. Oz Memory Quiz [28] ; Visual Association Test [30] ; and Dichotic Listening Test (DLT) [31] .
The Dr. Oz Memory Quiz is an alzheimer detection screening method, that is based on SLUMS test [28] . It is formed by 17 questions and tasks that score 1 point each.
In the case of Visual Association Test (VAT) [30] , six pairs of objects are shown consecutively, and after the patients memorize them, one object of each pair is shown and they have to recall its couple. This test gives a maximum score of 6 points, one per recalled couple.
During the Dichotic Listening Test (DLT), the patients have to memorise 6 digits played to each ear separately and the process is repeated 8 times [31] . As the results are stored by ear, the maximum score is 24 points per ear. This test is based on the fact that the difference of the recalled digits between the left and right ear in a healthy person is minimal compared with the predominance of
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the right ear for patients with Alzheimer's. Therefore, the data collected from this test is the difference of the left ear score minus the right ear score. The maximum score for each ear (24) is added in order to obtain positive values.
Finally, the maximum possible value is delimited to 24, since left predominance or both ear equivalence are considered as healthy results (DLTre -Dichotic
Listening Test right ear). In this way, the results decrease when the right ear predominance is high. In this way, these results and the ones obtained by the other tests can be compared. In addition, the number of digits recalled are also collected. This value will represent the memorization capacity.
Evaluation
The mean results for each test in relation to the subject's health status are shown in Table 3 on the Dichotic Listening test (DLTre). Table 4 demonstrates that the p-value of the novel tests proves that their results are correlated with the healthy and
Alzheimer's status of the patients. When it comes to sensitivity and specificity in relation to the detection of healthy patients, the results are perfect. This suggest that more subjects need to be tested in order to corroborate the results of the novel Alzheimer's screening tests. are based on a strong criteria, the addition of new ones will allow to increase the robustness of the test. with those factors. Therefore, tasks that are more difficult can be added for patients with high educational background in order to eliminate this correlation.
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When it comes to the relationship between the results and the gender of the participants, the results of the male participants and the females one are not correlated (see table 4 ).
The correlation between the DrOz, VAT and DLT tests, and the novel ones A C C E P T E D M A N U S C R I P T is shown in Table 5 , where the Spearman's correlation has been calculated, including the correlation coefficient and the p-value. Most of the novel tests result high correlation value with at least two of the previous tests.
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In addition to the numerical results, some notes were collected during the testing process that could be used by the doctors to make a decision. The most interesting of these notes is the lack of attention of Alzheimer's patients due to the animated virtual environment. For example, during VOM test there are some animated objects close to the questions area that divert the attention of the patients making them to forget about the task in progress. This reveals a problem in the Complex Attention cognitive domain.
Qualitative evaluation of the proposed system
At the end of the process, patients were asked to evaluate the application.
They had to fill a form evaluating the quality of the application in terms of interaction; simplicity of instructions/processes and the comfort of the VR glasses.
Additionally, the patients had the option to write any additional comments about the proposed cognitive tests. The average evaluation of the proposed approach was positive. Some of the subjects commented that the glasses were not comfortable at the end of the test and that the graphics could be improved, which is something that will be available in future versions of the hardware devices. Nevertheless, most of the participants evaluated the application as motivating and interesting; and the interaction and instructions as simple and easy to understand. Table 6 shows the overall evaluation of the proposed cognitive tests provided by the participants. The interaction with the application (i.e. keyboard, mouse, depth sensor and virtual reality glasses), the quality of the instructions (i.e.
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written and/or oral provided by the supervisor) and the comfort of the VR glasses were evaluated from 0 (really bad) to 5 points (really good). The overall evaluation obtained is positive, since the average result in all these categories is above 3 points, with elder people being more enthusiastic with new technologies, probably due to the completely new to them features and capabilities.
Conclusion
Alzheimer is a disease without foreseen cure, that is affecting more people every year, with the related research and associated services (care) cost to increase rapidly. Our objective is to provide affordable approaches that would help improving the current cognitive based detection systems.
Virtual Environments (VEs) start to be part of medical treatments or diagnosis methods, and they have been proved to be considerably useful by applying cognitive tests in secure and controlled environments; helping to increase the effectiveness of the related methodologies. These facts have been further vali- 
